Discontinued — last reported Q3 '22
CVS Health Acquisitions decreased by 97.6% to $7.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 30.0%, from $10.00M to $7.00M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 31.5% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $24.00M | $27.00M | $11.00M | $7.00M | $118.00M | $6.00M | $8.00M | $7.09B | $9.38B | $18.00M | $120.00M | $25.00M | $48.00M | $12.00M | $10.00M | $20.00M | $119.00M | $290.00M | $7.00M |
| QoQ Change | — | +12.5% | -59.3% | -36.4% | >999% | -94.9% | +33.3% | >999% | +32.2% | -99.8% | +566.7% | -79.2% | +92.0% | -75.0% | -16.7% | +100.0% | +495.0% | +143.7% | -97.6% |
| YoY Change | — | — | — | — | +391.7% | -77.8% | -27.3% | >999% | >999% | +200.0% | >999% | -99.6% | -99.5% | -33.3% | -91.7% | -20.0% | +147.9% | >999% | -30.0% |